Data Analytics

Envision Pharma Group Acquires

Pivotal acquisition in Envision Pharma Group’s tech-enabled offerings provides clients with access to advanced AI to accelerate decision-making that optimizes their products’ path to market and ultimately supports the delivery of enhanced patient outcomes.

Envision Pharma Group (Envision), a leading global technology-enabled commercialization, integrated medical capabilities and solutions, and data analytics partner to the life sciences industry, announced today it has acquired, an award-winning technology company active in the provision of artificial intelligence (AI) solutions with present brains across commercialization, real-world evidence and data analytics, medical, and pricing for the pharmaceutical and life sciences industry.’s AI products and solutions translate large clinical, scientific, and commercial data sets into actionable insights to empower decision-making and drive action to clients in the life sciences industry.

“We are delighted to welcome into the Envision Pharma Group family,” shares Meg Heim, CEO, Envision Pharma Group. “The acquisition of marks an exciting milestone in Envision’s evolution as we continue to accelerate and deliver a compelling combination of technology-enabled capabilities and solutions to clients. The combination of Envision’s leading technology, capabilities, and solutions with’s artificial intelligence solutions and expertise enables us to strengthen our offerings to clients across the product life cycle, but more importantly, support patients in their journey to health and wellness.”  

Dr. Loubna Bouarfa, founder of, will be joining Envision as a member of its Executive Leadership Team. Recently, Loubna won the prestigious Deloitte Fast 50 Women in Leadership Award and Forbes 50 Top Women in Tech. Loubna shares, “Today is a redefining moment for I am honored to be joining forces with Envision and see enormous opportunities for the growth of our combined expertise and solutions for clients in the life sciences industry. As part of Envision Pharma Group, we can accelerate our work to bring AI to the heart of decision-making across the life sciences industry. Our success will not only bring commercial benefit to clients but lead to improved patient outcomes across the globe.” 

Based in the U.K. and Netherlands, employs around 30 members of staff. The acquisition of will bring the total number of Envision Pharma Group to 1,400+ employees across four continents. 

Visit AITechPark for cutting-edge Tech Trends around AI, ML, Cybersecurity, along with AITech News, and timely updates from industry professionals!

Related posts

Validere Acquires Phoenix Energy Consultants

Business Wire

RiskOptics Names Lisa Mogensen as Chief Financial Officer

Business Wire

Vesttoo Announces Participation in IBM Alpha Zone Accelerator

PR Newswire